100
Participants
Start Date
June 12, 2024
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
TUB-040
A complete treatment cycle is defined as 21 calendar days. TUB-040 will be administered as an intravenous (IV) solution on day 1 of each treatment cycle
RECRUITING
UZ Leuven, Leuven
RECRUITING
Charité Universitätsmedizin Berlin, Berlin
RECRUITING
Next Oncology Virginia, Fairfax
RECRUITING
Clínica universidad de Navarra, Madrid
RECRUITING
NEXT Oncology Madrid, Madrid
RECRUITING
Christ Hospital, Cincinnati
RECRUITING
University Hospital Cologne Department of Internal Medicine I, Cologne
RECRUITING
OU Health Stephenson Cancer Center, Oklahoma City
RECRUITING
Next Oncology Dallas, Irving
RECRUITING
Arensia Exploratory Medicine, Cluj-Napoca
RECRUITING
Arensia Exploratory Medicine, Kyiv
RECRUITING
Guy's Hospital, London
Tubulis GmbH
INDUSTRY